{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:49:21Z","timestamp":1783478961232,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Novo Nordisk A\/S"},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk Health Care AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ghir.2019.09.002","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T17:39:19Z","timestamp":1572111559000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Growth hormone replacement in adults: Real-world data from two large studies in US and Europe"],"prefix":"10.1016","volume":"50","author":[{"given":"Matthias M.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray B.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"H\u00f6ybye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Otto L.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gediminas","family":"Puras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Popovic-Brkic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Molitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlady","family":"Ostrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Holot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pietropoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly M.K.","family":"Biller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2265.1995.tb01860.x","article-title":"Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2265.2001.01320.x","article-title":"Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities","volume":"55","author":"Abdu","year":"2001","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/EJE-10-0009","article-title":"Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement","volume":"163","author":"Gotherstrom","year":"2010","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2019.09.002_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2265.1993.tb00974.x","article-title":"Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency","volume":"38","author":"Rosen","year":"1993","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2019.09.002_bb0025","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1210\/jcem.84.4.5614","article-title":"Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults","volume":"84","author":"Maghnie","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0040","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0045","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2019.09.002_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030893","article-title":"Treatment with growth hormone for adults with growth hormone deficiency syndrome: benefits and risks","volume":"19","author":"Diez","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ghir.2019.09.002_bb0055","first-page":"1341","article-title":"Randomized controlled trials - a matter of design","volume":"12","author":"Spieth","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.ghir.2019.09.002_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12871-016-0265-3","article-title":"Randomized controlled trials vs. observational studies: why not just live together?","volume":"16","author":"Faraoni","year":"2016","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.ghir.2019.09.002_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/CLEP.S42602","volume":"5","author":"Hoybye","year":"2013","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ghir.2019.09.002_bb0070","series-title":"Aetiology of growth hormone deficiency (KIMS classification list), Growth Hormone Deficiency in Adults: 10 Years in KIMS","first-page":"346","author":"Abs R","year":"2004"},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2019.09.002_bb0075","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1530\/EJE-09-0273","article-title":"Etiology, baseline characteristics, and biochemical diagnosis of GH deficiency in the adult: are there regional variations?","volume":"161","author":"Brabant","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0080","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/jc.2008-0713","article-title":"Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database","volume":"94","author":"Webb","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2019.09.002_bb0085","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4158\/EP161407.DSCR","volume":"22","author":"Yuen","year":"2016","journal-title":"Endocr. Pract."},{"issue":"3","key":"10.1016\/j.ghir.2019.09.002_bb0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11102-016-0712-7","article-title":"Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study","volume":"19","author":"Hamrahian","year":"2016","journal-title":"Pituitary"},{"issue":"12","key":"10.1016\/j.ghir.2019.09.002_bb0095","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1210\/jc.2014-2830","article-title":"Overweight\/obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency","volume":"99","author":"Dichtel","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0100","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s11102-015-0666-1","article-title":"Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?","volume":"18","author":"Diri","year":"2015","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.ghir.2019.09.002_bb0105","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijrobp.2014.01.019","article-title":"Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience","volume":"88","author":"Lo","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00006123-199702000-00001","article-title":"Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience","volume":"40","author":"Ciric","year":"1997","journal-title":"Neurosurgery"},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2019.09.002_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr. Pract."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2019.09.002_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000329156","article-title":"Lessons learned from 15 years of KIMS and 5 years of ACROSTUDY","volume":"76","author":"Luger","year":"2011","journal-title":"Hormone Res. Paed."},{"issue":"4","key":"10.1016\/j.ghir.2019.09.002_bb0125","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4158\/EP14603.OR","article-title":"Trends in growth hormone stimulation testing and growth hormone dosing in adult growth hormone deficiency patients: results from the ANSWER Program","volume":"22","author":"Gordon","year":"2016","journal-title":"Endocr. Pract."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0130","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/cen.13330","article-title":"Is GH dosing optimal in female patients with adult-onset GH deficiency? An analysis from the NordiNet((R)) International Outcome Study","volume":"86","author":"Hoybye","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"5 Suppl","key":"10.1016\/j.ghir.2019.09.002_bb0135","first-page":"58","article-title":"Gender difference in growth hormone response in adults","volume":"22","author":"Johansson","year":"1999","journal-title":"J. Endocrinol. Investig."},{"issue":"11","key":"10.1016\/j.ghir.2019.09.002_bb0140","first-page":"3956","article-title":"Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults","volume":"84","author":"Cook","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2019.09.002_bb0145","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2265.2007.02783.x","article-title":"Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study","volume":"66","author":"Sonnet","year":"2007","journal-title":"Clin. Endocrinol."},{"issue":"26","key":"10.1016\/j.ghir.2019.09.002_bb0150","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ghir.2019.09.002_bb0155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/EJE-12-1083","article-title":"Fifteen years of GH replacement improves body composition and cardiovascular risk factors","volume":"168","author":"Elbornsson","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2019.09.002_bb0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults","volume":"16","author":"de Boer","year":"1995","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0165","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1530\/EJE-15-0305","article-title":"Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency","volume":"173","author":"Schneider","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2019.09.002_bb0170","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000355822","article-title":"Effectiveness of a low-calorie weight loss program in moderately and severely obese patients","volume":"6","author":"Winkler","year":"2013","journal-title":"Obesity Facts"},{"issue":"8","key":"10.1016\/j.ghir.2019.09.002_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13080821","article-title":"Age-related changes in segmental body composition by ethnicity and history of weight change across the adult lifespan","volume":"13","author":"Tian","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ghir.2011.01.001","article-title":"Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency","volume":"21","author":"Jorgensen","year":"2011","journal-title":"Growth Hormone & IGF Res. Official J. Growth Hormone Res. Soc. Int. IGF Res. Soc."},{"issue":"4","key":"10.1016\/j.ghir.2019.09.002_bb0185","first-page":"1600","article-title":"Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS database","volume":"87","author":"Attanasio","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2019.09.002_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ghir.2015.06.006","article-title":"Reviewing the safety of GH replacement therapy in adults","volume":"25","author":"Stochholm","year":"2015","journal-title":"Growth Hormone & IGF Res. Official J. Growth Hormone Res. Soc. Int. IGF Res. Soc."},{"issue":"4","key":"10.1016\/j.ghir.2019.09.002_bb0195","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/cen.13502","article-title":"Long-term safety of growth hormone-a combined registry analysis","volume":"88","author":"Stochholm","year":"2018","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0200","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2265.1999.00695.x","article-title":"GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety","volume":"50","author":"Abs","year":"1999","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0205","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40618-016-0604-8","article-title":"Long-term safety and efficacy of Omnitrope(\u00ae) in adults with growth hormone deficiency: Italian interim analysis of the PATRO adults study","volume":"40","author":"Ferone","year":"2017","journal-title":"J. Endocrinol. Investig."},{"issue":"3","key":"10.1016\/j.ghir.2019.09.002_bb0210","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1210\/jc.2012-2684","article-title":"Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients","volume":"98","author":"Hartman","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ghir.2019.09.002_bb0215","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40618-017-0818-4","article-title":"Multi-Centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency","volume":"41","author":"Johannsson","year":"2018","journal-title":"J. Endocrinol. Investig."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0220","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/cen.13256","article-title":"The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet((R)) International Outcome Study","volume":"86","author":"Weber","year":"2017","journal-title":"Clin. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2019.09.002_bb0225","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2011-0448","article-title":"Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis","volume":"96","author":"Attanasio","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2019.09.002_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/dc11-0449","article-title":"Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study","volume":"35","author":"Luger","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ghir.2019.09.002_bb0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jc.2009-1326","article-title":"Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement","volume":"95","author":"Attanasio","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0240","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-14-1123","article-title":"Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study","volume":"172","author":"Child","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/jc.2017-01899","article-title":"New neoplasm during GH replacement in adults with pituitary deficiency following malignancy: a KIMS analysis","volume":"103","author":"Krzyzanowska-Mittermayer","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ghir.2019.09.002_bb0250","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2019.09.002_bb0255","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ghir.2019.09.002_bb0260","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1210\/jc.2018-01205","article-title":"GH therapy in childhood Cancer survivors: a systematic review and meta-analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ghir.2019.09.002_bb0265","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1210\/jc.2014-1814","article-title":"Socioeconomic factors do not but GH treatment does affect mortality in adult-onset growth hormone deficiency","volume":"99","author":"Stochholm","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2019.09.002_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-16-0450","article-title":"Life expectancy in patients with pituitary adenoma receiving growth hormone replacement","volume":"176","author":"Olsson","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2019.09.002_bb0275","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/cen.12848","article-title":"Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency","volume":"83","author":"Berglund","year":"2015","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2019.09.002_bb0280","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/jc.2014-3787","article-title":"Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies","volume":"100","author":"Pappachan","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2019.09.002_bb0285","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pds.1510","article-title":"Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database)","volume":"17","author":"Gutierrez","year":"2008","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/picr.PICR_36_18","article-title":"Real world evidence (RWE) - are we (RWE) ready?","volume":"9","author":"Suvarna","year":"2018","journal-title":"Perspect. Clin. Res."},{"key":"10.1016\/j.ghir.2019.09.002_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2018.10.004","article-title":"Long-term adherence to growth hormone therapy in a large health maintenance organization cohort","volume":"44","author":"Farfel","year":"2018","journal-title":"Growth Hormone & IGF Res. Official J. Growth Hormone Res. Soc. Int. IGF Res. Soc."},{"issue":"2","key":"10.1016\/j.ghir.2019.09.002_bb0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4158\/EP.14.2.143","article-title":"Compliance and persistence in pediatric and adult patients receiving growth hormone therapy","volume":"14","author":"Rosenfeld","year":"2008","journal-title":"Endocr. Pract."},{"issue":"3","key":"10.1016\/j.ghir.2019.09.002_bb0305","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ghir.2015.03.001","article-title":"The robustness of diagnostic tests for GH deficiency in adults","volume":"25","author":"Andersen","year":"2015","journal-title":"Growth Hormone & IGF Res. Official J. Growth Hormone Res. Soc. Int. IGF Res. Soc"},{"issue":"1","key":"10.1016\/j.ghir.2019.09.002_bb0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ghir.2014.12.001","article-title":"Management and interpretation of heterogeneous observational data: using insulin-like growth factor-I data from the NordiNet(R) International Outcome Study","volume":"25","author":"Blankenstein","year":"2015","journal-title":"Growth Hormone & IGF Res. Official J. Growth Hormone Res. Soc. Int. IGF Res. Soc."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637419300437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637419300437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:04Z","timestamp":1761087124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637419300437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":62,"alternative-id":["S1096637419300437"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2019.09.002","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone replacement in adults: Real-world data from two large studies in US and Europe","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2019.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}